hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients.
Iorio J, Lastraioli E, Tofani L, Petroni G, Antonuzzo L, Messerini L, Perrone G, Caputo D, Francesconi M, Amato MM, Cadei M, Arcangeli G, Villanacci V, Boni L, Coppola R, Di Costanzo F, Arcangeli A.
Iorio J, et al. Among authors: cadei m.
Transl Oncol. 2020 Mar;13(3):100740. doi: 10.1016/j.tranon.2020.01.001. Epub 2020 Feb 25.
Transl Oncol. 2020.
PMID: 32105990
Free PMC article.